Open AccessReactivation risk of Hepatitis B Virus in both HBsAg negative and HBcIgG positive patients with solid malignancy. Is antiviral prophylaxis really necessary?
Author(s) -
Murat Araz,
İsmail Beypınar,
Tarık Demir,
Hacer Demir,
Mükremın Uysal
Publication year - 2019
Publication title -
medicine science
Language(s) - English
Resource type - Journals
ISSN - 2147-0634
DOI - 10.5455/medscience.2019.08.9009
Subject(s) - medicine , hbsag , chemotherapy , malignancy , hepatitis b virus , population , regimen , cancer , gastroenterology , stage (stratigraphy) , oncology , virus , immunology , paleontology , environmental health , biology